Pill Identifier App

Label Changes for:

Xeomin (Incobotulinumtoxin A) for Injection

April 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

 

ADVERSE REACTIONS

Post-marketing Experience
  • …flu-like symptoms…
Hide
(web5)